PodcastIntel
Sign in Get Started Free
Citeline Podcasts
Citeline Podcasts

Strategic Intent: Rubedo’s Seno-Adaptive Bet On Longevity Medicine

Sep 21, 2026 · 40m
✨ AI Summary
  • Rubedo Life Sciences focuses on turning aging biology into medicines.
  • Lead topical modulator RLS‑1496 targets skin conditions and alopecia.
  • Company employs a 'seno-adaptive' approach to cellular aging.

Guests on This Episode

FB
Frederick Beddingfield
1 podcast appearance

More from Citeline Podcasts

View all episodes →

Get AI Summaries for Every New Episode

Subscribe to Citeline Podcasts and get AI summaries, guest tracking, and email digests delivered automatically.

Sign Up Free →